Cardiomyocyte crosstalk with endothelium modulates cardiac structure, function, and ischemia-reperfusion injury susceptibility through erythropoietin.
Marrow, Jade P, Alshamali, Razan, Edgett, Brittany A, Allwood, Melissa A, Cochrane, Kyla L S, Al-Sabbag, Sara, Ayoub, Anmar, Ask, Kjetil, Hare, Gregory M T, Brunt, Keith R and Simpson, Jeremy A (2024) Cardiomyocyte crosstalk with endothelium modulates cardiac structure, function, and ischemia-reperfusion injury susceptibility through erythropoietin. Frontiers in physiology, 15. p. 1397049. ISSN 1664-042X
Abstract
Erythropoietin (EPO) exerts non-canonical roles beyond erythropoiesis that are developmentally, structurally, and physiologically relevant for the heart as a paracrine factor. The role for paracrine EPO signalling and cellular crosstalk in the adult is uncertain. Here, we provided novel evidence showing cardiomyocyte restricted loss of function in in adult mice induced hyper-compensatory increases in expression by adjacent cardiac endothelial cells via HIF-2α independent mechanisms. These hearts showed concentric cellular hypertrophy, elevated contractility and relaxation, and greater resistance to ischemia-reperfusion injury. Voluntary exercise capacity compared to control hearts was improved independent of any changes to whole-body metabolism or blood O content or delivery (i.e., hematocrit). Our findings suggest cardiac EPO had a localized effect within the normoxic heart, which was regulated by cell-specific EPO-reciprocity between cardiomyocytes and endothelium. Within the heart, hyper-compensated endo
Item Type: | Article |
---|---|
Date Deposited: | 28 Dec 2024 00:45 |
Last Modified: | 28 Dec 2024 00:45 |
URI: | https://oak.novartis.com/id/eprint/56181 |